Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5183836 | 0.94 | EPHX1 (0.37) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL21522637 | 0.93 | EPHX1 (0.40) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL29233375 | 0.93 | EPHX1 (0.40) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL20240978 | 0.93 | EPHX1 (0.40) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL7102818 | 0.93 | EPHX1 (0.40) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL29233372 | 0.93 | EPHX1 (0.40) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL51769 | 0.88 | — | — | |
| SCHEMBL4929388 | 0.83 | CYP1A2 (0.36) | EPHX1CYP1A2ALDH1A1TDP1 | |
| SCHEMBL20535377 | 0.81 | — | — | |
| SCHEMBL4432862 | 0.81 | SIGMAR1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 159 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11667780-B2 | Impact modified styrene copolymer composition comprising polysiloxane additive having improved abrasion characteristics | INEOS STYROLUTION GROUP GMBH (DE) | 2023-06-06 | — | — | US | claimed |
| CN-111247205-A | Impact modified styrenic copolymer compositions containing polysiloxane additives with improved abrasion resistance | 英力士苯领集团股份公司 | 2020-06-05 | — | — | CN | claimed |
| EP-3658623-A1 | IMPACT MODIFIED STYRENE COPOLYMER COMPOSITION COMPRISING POLYSILOXANE ADDITIVE HAVING IMPROVED ABRASION CHARACTERISTICS | INEOS Styrolution Group GmbH (DE) | 2020-06-03 | — | — | EP | claimed |
| US-20200148872-A1 | IMPACT MODIFIED STYRENE COPOLYMER COMPOSITION COMPRISING POLYSILOXANE ADDITIVE HAVING IMPROVED ABRASION CHARACTERISTICS | HSBC CORPORATE TRUSTEE COMPANY (UK) LIMITED (GB) | 2020-05-14 | — | — | US | claimed |
| WO-2019020677-A1 | IMPACT MODIFIED STYRENE COPOLYMER COMPOSITION COMPRISING POLYSILOXANE ADDITIVE HAVING IMPROVED ABRASION CHARACTERISTICS | INEOS STYROLUTION GROUP GMBH (DE) | 2019-01-31 | — | — | WO | claimed |
| WO-2018104079-A1 | PIPE PRODUCED WITH A POLYMER COMPOSITION COMPRISING A POLYOLEFIN | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2018-06-14 | — | — | WO | claimed |
| US-9771495-B2 | Low temperature segmented copolymer compositions and methods | THE BOEING COMPANY (US) | 2017-09-26 | — | — | US | claimed |
| US-20160312066-A1 | LOW TEMPERATURE SEGMENTED COPOLYMER COMPOSITIONS AND METHODS | THE BOEING COMPANY | 2016-10-27 | — | — | US | claimed |
| US-9388272-B2 | Low temperature segmented copolymer compositions and methods | THE BOEING COMPANY (US) | 2016-07-12 | — | — | US | claimed |
| US-20150133602-A1 | LOW TEMPERATURE SEGMENTED COPOLYMER COMPOSITIONS AND METHODS | THE BOEING COMPANY | 2015-05-14 | — | — | US | claimed |
| EP-2601245-A1 | CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF | Biofilm IP, LLC (US) | 2013-06-12 | — | — | EP | claimed |
| US-8334356-B1 | Low temperature segmented copolymer compositions and methods | THE BOEING COMPANY (US) | 2012-12-18 | — | — | US | claimed |
| US-20120128874-A1 | LUBRICIOUS COATINGS | TYCO HEALTHCARE GROUP LP | 2012-05-24 | — | — | US | claimed |
| US-20120064022-A1 | CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF | BIOFILM, INC. | 2012-03-15 | — | — | US | claimed |
| US-8128599-B2 | Lubricious coatings | TYCO HEALTHCARE GROUP LP (US) | 2012-03-06 | — | — | US | claimed |
| WO-2012018403-A1 | CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF | BIOFILM IP, LLC (US) | 2012-02-09 | — | — | WO | claimed |
| US-20090024097-A1 | LUBRICIOUS COATINGS | TYCO HEALTHCARE GROUP LP | 2009-01-22 | — | — | US | claimed |
| EP-2016972-A2 | Lubricious coatings | Tyco Healthcare Group LP (US) | 2009-01-21 | — | — | EP | claimed |
| EP-1813295-A2 | Coated surgical needles | TYCO HEALTHCARE GROUP LP (US) | 2007-08-01 | — | — | EP | claimed |
| US-5527484-A | A MIXTURE OF PROTEASE AND AMYLASE ENZYMES | COLGATE-PALMOLIVE CO. (US) | 1996-06-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120064022-A1 | CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF | PIEZO1, DSC1, PFAS | EPHX1 2029/4885CYP1A2 4097/4885ALDH1A1 4496/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.